Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Gross Margin: 2010-2012

Historic Gross Margin for Sonoma Pharmaceuticals (SNOA) over the last 3 years, with Dec 2012 value amounting to 69.80%.

  • Sonoma Pharmaceuticals' Gross Margin rose 342.00% to 69.80% in Q4 2012 from the same period last year, while for Dec 2012 it was 69.11%, marking a year-over-year decrease of 119.00%. This contributed to the annual value of 68.38% for FY2012, which is 542.00% up from last year.
  • Per Sonoma Pharmaceuticals' latest filing, its Gross Margin stood at 69.80% for Q4 2012, which was down 1.27% from 70.70% recorded in Q3 2012.
  • In the past 5 years, Sonoma Pharmaceuticals' Gross Margin ranged from a high of 75.84% in Q3 2011 and a low of 49.68% during Q4 2010.
  • In the last 3 years, Sonoma Pharmaceuticals' Gross Margin had a median value of 67.84% in 2010 and averaged 66.73%.
  • As far as peak fluctuations go, Sonoma Pharmaceuticals' Gross Margin soared by 1,670bps in 2011, and later tumbled by 748bps in 2012.
  • Sonoma Pharmaceuticals' Gross Margin (Quarterly) stood at 49.68% in 2010, then skyrocketed by 1,670bps to 66.38% in 2011, then spiked by 342bps to 69.80% in 2012.
  • Its Gross Margin stands at 69.80% for Q4 2012, versus 70.70% for Q3 2012 and 71.19% for Q2 2012.